JP2005514940A5 - - Google Patents

Download PDF

Info

Publication number
JP2005514940A5
JP2005514940A5 JP2003561519A JP2003561519A JP2005514940A5 JP 2005514940 A5 JP2005514940 A5 JP 2005514940A5 JP 2003561519 A JP2003561519 A JP 2003561519A JP 2003561519 A JP2003561519 A JP 2003561519A JP 2005514940 A5 JP2005514940 A5 JP 2005514940A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
amino acid
acid sequence
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003561519A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005514940A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/001450 external-priority patent/WO2003061573A2/en
Publication of JP2005514940A publication Critical patent/JP2005514940A/ja
Publication of JP2005514940A5 publication Critical patent/JP2005514940A5/ja
Pending legal-status Critical Current

Links

JP2003561519A 2002-01-18 2003-01-16 １４３５分子、５５９分子、３４０２１分子、４４０９９分子、２５２７８分子、６４１分子、２６０分子、５５０８９分子、２１４０７分子、４２０３２分子、４６６５６分子、６２５５３分子、３０２分子、３２３分子、１２３０３分子、９８５分子、１３２３７分子、１３６０１分子、１８９２６分子、３１８分子、２０５８分子または６３５１分子を用いる泌尿器疾患を処置するための方法および組成物 Pending JP2005514940A (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US34951102P 2002-01-18 2002-01-18
US36050002P 2002-02-28 2002-02-28
US36504102P 2002-03-15 2002-03-15
US37406302P 2002-04-19 2002-04-19
US40346802P 2002-08-14 2002-08-14
US41426202P 2002-09-27 2002-09-27
US41998602P 2002-10-21 2002-10-21
US42380902P 2002-11-05 2002-11-05
US42979702P 2002-11-26 2002-11-26
PCT/US2003/001450 WO2003061573A2 (en) 2002-01-18 2003-01-16 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo

Publications (2)

Publication Number Publication Date
JP2005514940A JP2005514940A (ja) 2005-05-26
JP2005514940A5 true JP2005514940A5 (enExample) 2006-02-16

Family

ID=27618013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003561519A Pending JP2005514940A (ja) 2002-01-18 2003-01-16 １４３５分子、５５９分子、３４０２１分子、４４０９９分子、２５２７８分子、６４１分子、２６０分子、５５０８９分子、２１４０７分子、４２０３２分子、４６６５６分子、６２５５３分子、３０２分子、３２３分子、１２３０３分子、９８５分子、１３２３７分子、１３６０１分子、１８９２６分子、３１８分子、２０５８分子または６３５１分子を用いる泌尿器疾患を処置するための方法および組成物

Country Status (5)

Country Link
US (2) US20030148394A1 (enExample)
EP (1) EP1472376A4 (enExample)
JP (1) JP2005514940A (enExample)
AU (1) AU2003210554A1 (enExample)
WO (1) WO2003061573A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514034A (ja) * 2001-12-31 2005-05-19 アルゴス セラピューティクス，インコーポレーテッド Ｐ２ｘ２を調節するための方法及び物質
WO2004042407A1 (en) * 2002-11-04 2004-05-21 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 73a (gpr73a)
US8187810B2 (en) * 2007-05-16 2012-05-29 Wellman Wai-Man Cheung Method for diagnosing overactive bladder
WO2010059982A1 (en) * 2008-11-21 2010-05-27 Martin Heath Bluth Diagnosing and monitoring response to treatment of solid organ tissue disease
WO2025166351A1 (en) * 2024-02-01 2025-08-07 Massachusetts Eye And Ear Infirmary Compositions and methods for hearing loss

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3955316B2 (ja) * 1991-06-21 2007-08-08 ザ・ワルター・アンド・エリザ・ホール・インスティテュート・オヴ・メディカル・リサーチ 新規レセプター型チロシンキナーゼ及びその用途
US6242216B1 (en) * 1997-11-14 2001-06-05 Abbott Laboratories Nucleic acids encoding a functional human purinoreceptor P2X2 and P2X4, and methods of production and use thereof
WO1999037811A1 (en) * 1998-01-21 1999-07-29 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US6780596B2 (en) * 1998-09-17 2004-08-24 Ashni Naturaceuticals, Inc. Methods for determining the activity of complex mixtures
EP1165776A1 (en) * 1999-02-22 2002-01-02 Ludwig Institute For Cancer Research TYROSINE KINASE RECEPTOR EphA3 ANTIGENIC PEPTIDES
GB9926805D0 (en) * 1999-11-13 2000-01-12 Zeneca Ltd Diagnostic methods
US6413757B1 (en) * 2000-02-28 2002-07-02 Millennium Pharmaceuticals, Inc. 25312, a novel human agmatinase-like homolog
EP1358349A2 (en) * 2000-06-05 2003-11-05 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets
AUPQ968700A0 (en) * 2000-08-28 2000-09-21 Intreat Pty Limited Treatment of urinary incontinence
US20070014801A1 (en) * 2001-01-24 2007-01-18 Gish Kurt C Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
US20020111302A1 (en) * 2000-11-30 2002-08-15 Y. Tom Tang Novel nucleic acids and polypeptides
US7459539B2 (en) * 2000-12-15 2008-12-02 Agensys, Inc. Antibody that binds zinc transporter protein 108P5H8

Similar Documents

Publication Publication Date Title
JP2005522999A5 (enExample)
Bacsi et al. Orientation of the heterodimeric aryl hydrocarbon (dioxin) receptor complex on its asymmetric DNA recognition sequence.
EP4085151A1 (en) In situ rna analysis using probe pair ligation
JP2023529682A (ja) 試料中の異なる分析物を検出するための多重的方法
JP2010508855A5 (enExample)
JP2008249727A5 (enExample)
RU2009135270A (ru) Способы выявления воспалительного заболевания кишечника
DK1305636T3 (da) Screeningsmetode
JP2008512984A5 (enExample)
JP2005535289A5 (enExample)
JP2005514940A5 (enExample)
JP2005511023A5 (enExample)
JP2005525112A5 (enExample)
JP2010131022A5 (enExample)
JP2006503575A5 (enExample)
KR101238196B1 (ko) 대장암의 간 전이 진단용 조성물 및 그 용도
JP2002523094A5 (enExample)
JP2005508172A5 (enExample)
JP2005508169A5 (enExample)
CN103451265A (zh) 电场作用下用微孔阵列固液相捕获单分子模板dna的方法
WO2004042345A3 (en) Bacterial small-molecule three-hybrid system
JP2005512528A5 (enExample)
CN113260451A (zh) 单分子表观遗传定位
JP2006501465A5 (enExample)
JP2005514013A5 (enExample)